glp.1 Decoding GLP-1 Weight Loss Medications Bariatric Fusion GLP Navigating GLP-1 use in therapy

In interviews and focus groups with employers, virtually every participant that covered these drugs for weight loss purposes highlighted the cost challenges

Choose soft protein first

Another key mechanism by which DPP-4 inhibitors improve glycemic control is through the inhibition of glucagon production, driven by the GLP-1 effect (22)

Exendin-4, a Glucagon-Like Protein-1 (GLP-1) Receptor Agonist, Reverses Hepatic Steatosis in Ob/Ob Mice

Characterized by cell injury and inflammatory cell infiltration, NASH is regarded as a more aggressive form of NAFLD possibly progressing to cirrhosis and hepatocellular carcinoma with limited treatment options (118) and with a history of NASH, the possibility of suffering liver and cardiovascular diseases is greatly increased (119)